Congenital intestinal fibrosarcoma with rapid recurrence requiring adjuvant chemotherapy

Pediatr Int. 2017 Jun;59(6):733-736. doi: 10.1111/ped.13252. Epub 2017 Apr 24.

Abstract

A total of 16 cases of congenital fibrosarcoma have been reported from 1975 to March 2015. Five of the 16 had abnormal fusion between erythroblast transformation specific translocation variant 6 and neurotrophin recptor gene neurotrophic tyrosine kinase, receptor, type 3 (ETV6-NTRK3); in another five out of 16 this was absent, and six were not tested. All were managed by surgical resection but none involved metastasis. Herein we report the case of a newborn baby girl with congenital fibrosarcoma negative for ETV6-NTRK3 gene fusion, who presented with ileal perforation and positive resection margin. She had rapid recurrence with lymph node metastasis treated with postoperative chemotherapy. There was no further recurrence at >3 years of follow up.

Keywords: chemotherapy; congenital fibrosarcoma; intestinal; metastasis; rare tumor.

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Chemotherapy, Adjuvant
  • Colectomy
  • Female
  • Fibrosarcoma / congenital
  • Fibrosarcoma / drug therapy*
  • Fibrosarcoma / pathology
  • Fibrosarcoma / surgery
  • Humans
  • Ileal Neoplasms / congenital
  • Ileal Neoplasms / drug therapy*
  • Ileal Neoplasms / pathology
  • Ileal Neoplasms / surgery
  • Infant, Newborn
  • Intestine, Small / surgery*
  • Jejunal Neoplasms / congenital
  • Jejunal Neoplasms / drug therapy*
  • Jejunal Neoplasms / pathology
  • Jejunal Neoplasms / surgery
  • Lymphatic Metastasis
  • Neoplasm Recurrence, Local / drug therapy*
  • Neoplasm Recurrence, Local / pathology
  • Neoplasm Recurrence, Local / surgery

Substances

  • Antineoplastic Agents